Return to homepagePandemic Pact

Profile-Covid Rapid diagnostic profiling of SARS-CoV-2 in the context of persistent immune activation in sub-Saharan Africa

  • Funded by European & Developing Countries Clinical Trials Partnership (EDCTP)
  • Total publications:1 publications

Grant number: RIA2020EF-2905

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020

  • Known Financial Commitments (USD)

    $559,529.6

  • Funder

    European & Developing Countries Clinical Trials Partnership (EDCTP)

  • Principal Investigator

    Dr. Dawit Wolday

  • Research Location

    Ethiopia, Ghana

  • Lead Research Institution

    Mekelle University

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The Profile-Cov project (RIA2020EF-2905) aims to evaluate the profile of the immune response of the Ethiopian population and will examine its relationship with the noted low CD4+ T-cell count and underlying immune activation status among patients with COVID-19 and will compare the results with data collected in Europe.

1 Publication linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

Chronic Immune Activation and CD4+ T Cell Lymphopenia in Healthy African Individuals: Perspectives for SARS-CoV-2 Vaccine Efficacy.